Read the latest news from Saama.
CAMPBELL, CA – (November 19, 2021) – Saama Technologies, LLC. (“Saama”) today announced the appointment of six individuals to its Board of Directors. Saama board
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
Private Equity Powerhouse Leads Group of Investors Bullish on AI Leading business publication Forbes broke the news of Saama’s $430 million funding deal with a
Saama’s customized cloud strategy aligned with AWS Saama Smart Applications for fast-tracked clinical innovation supported by AWS Saama ensures faster, safer clinical development via AWS
Digital Transformation Included a Focus on Data Quality This article from Analytics Insight explains how Pfizer’s willingness to embrace digital transformation and artificial intelligence (AI)
Learning Lessons from Abbott’s Global Pandemic Defense Coalition In response to an article in Modern Healthcare on the Abbott Pandemic Defense Coalition, Nekzad Shroff, Saama’s
Smart Data Query “Saved…an Entire Month” As Pfizer scientists raced to develop its COVID-19 vaccine at record-breaking speed, they developed an innovative artificial intelligence (AI)
List compiled by David Shulkin, M.D., 9th Secretary of the US Department of Veteran Affairs Saama honored in Drug Development and Clinical Trials category Saama’s
CAMPBELL, CA – (October 26, 2020) – Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today the launch of the new
